PHLDA2 antibody (C-Term)
Quick Overview for PHLDA2 antibody (C-Term) (ABIN185132)
Target
See all PHLDA2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Binding Specificity
- C-Term
-
Purpose
- PHLDA2 / IPL
-
Sequence
- EPSRPSPQPK PRTP
-
Cross-Reactivity
- Human
-
Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogen
- Peptide with sequence C-EPSRPSPQPKPRTP, from the C Terminus of the protein sequence according to NP_003302.1.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Immunohistochemistry: Paraffin embedded Human Placenta and Prostate. Recommended concentration: 3.75 μg/mL.
Western Blot: Preliminary experiments gave no signal but low background in Jurkat and human placenta extracts at up to 1 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:32000.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Minimize freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- PHLDA2 (Pleckstrin Homology-Like Domain, Family A, Member 2 (PHLDA2))
-
Alternative Name
- PHLDA2
-
Background
- PHLDA2, pleckstrin homology-like domain, family A, member 2, TSSC3, IPL, BRW1C, BWR1C, HLDA2, PHLDA2, tumor suppressing subtransferable candidate 3, tumor-supressing STF cDNA 3, imprinted in placenta and liver, p17-Beckwith-Wiedemann region 1C, pleckstrin
-
Gene ID
- 7262
-
NCBI Accession
- NP_003302
-
Pathways
- Regulation of Carbohydrate Metabolic Process
Target
-